Xeme Biopharma Inc.   Report issue

For profit Phase 2
Founded: Lombard IL United States (2005)

Organization Overview

First Clinical Trial
2013
NCT01976520
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

XEME Biopharma Inc.